% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Delacher:153096,
author = {M. Delacher$^*$ and C. D. Imbusch$^*$ and A.
Hotz-Wagenblatt$^*$ and J.-P. Mallm$^*$ and K. Bauer$^*$ and
M. Simon$^*$ and D. Riegel and A. F. Rendeiro and S. Bittner
and L. Sanderink and A. Pant and L. Schmidleithner and K.
Braband$^*$ and B. Echtenachter and A. Fischer and V.
Giunchiglia and P. Hoffmann and M. Edinger and C. Bock and
M. Rehli and B. Brors$^*$ and C. Schmidl and M. Feuerer$^*$},
title = {{P}recursors for {N}onlymphoid-{T}issue {T}reg {C}ells
{R}eside in {S}econdary {L}ymphoid {O}rgans and {A}re
{P}rogrammed by the {T}ranscription {F}actor {BATF}.},
journal = {Immunity},
volume = {52},
number = {2},
issn = {1074-7613},
address = {New York, NY},
publisher = {Elsevier},
reportid = {DKFZ-2020-00178},
pages = {295-312.e11},
year = {2020},
note = {2020 Feb 18;52(2):295-312.e11#EA:D100#EA:B330#LA:D100#},
abstract = {Specialized regulatory T (Treg) cells accumulate
and perform homeostatic and regenerative functions in
nonlymphoid tissues. Whether common precursors for
nonlymphoid-tissue Treg cells exist and how they
differentiate remain elusive. Using transcription factor
nuclear factor, interleukin 3 regulated (Nfil3) reporter
mice and single-cell RNA-sequencing (scRNA-seq), we
identified two precursor stages of interleukin 33 (IL-33)
receptor ST2-expressing nonlymphoid tissue Treg cells, which
resided in the spleen and lymph nodes. Global chromatin
profiling of nonlymphoid tissue Treg cells and the two
precursor stages revealed a stepwise acquisition of
chromatin accessibility and reprogramming toward the
nonlymphoid-tissue Treg cell phenotype. Mechanistically, we
identified and validated the transcription factor Batf as
the driver of the molecular tissue program in the
precursors. Understanding this tissue development program
will help to harness regenerative properties of tissue Treg
cells for therapy.},
cin = {D100 / B330 / W610 / W192 / B066 / HD01},
ddc = {610},
cid = {I:(DE-He78)D100-20160331 / I:(DE-He78)B330-20160331 /
I:(DE-He78)W610-20160331 / I:(DE-He78)W192-20160331 /
I:(DE-He78)B066-20160331 / I:(DE-He78)HD01-20160331},
pnm = {314 - Tumor immunology (POF3-314)},
pid = {G:(DE-HGF)POF3-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31924477},
doi = {10.1016/j.immuni.2019.12.002},
url = {https://inrepo02.dkfz.de/record/153096},
}